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DObjectives: We sought to elucidate late functional outcomes of the right ventricular outflow tract and
atrioventricular valves after repair of tetralogy of Fallot with atrioventricular septal defect.
Methods: From 1990 to 2010, the data from 41 patients who underwent repair were retrospectively reviewed.
The median age at repair was 22.4 months (interquartile range, 10.8-41.6 months). Of the 41 patients, 13 (32%)
had received previous palliations. The preoperative anatomic differences, physiologic differences, and long-
term functional outcomes were determined using a double case-matched control with isolated tetralogy of Fallot
and isolated atrioventricular septal defect.
Results: The right ventricular outflow tract was reconstructed, with the pulmonary valve preserved in 23 patients
(56%). Therewere 3 early deaths and no late deaths. Survival was 92.1% at 15 years. During amedian follow-up
period of 5.9 years (interquartile range, 0.14-13.7 years), 29 reinterventions were performed in 13 (32%)
patients. Freedom from all reintervention at 15 years was 52.8%. Of the 29 procedures, 12 (41%) were related
to the right ventricular outflow tract. Freedom from right ventricular outflow tract-related reintervention was
greater in patients who had their pulmonary valve preserved (95% vs 70% at 10 years; P ¼ .046). Reinterven-
tions were performed for the atrioventricular valve in 2 (5%) patients and subaortic stenosis in 1 (2%) patient.
Freedom from right ventricular outflow tract-related reintervention (tetralogy of Fallot with atrioventricular sep-
tal defect, 88.6% vs tetralogy of Fallot alone, 83.9% at 5 years; P ¼ .809) and atrioventricular valve/left ven-
tricular outflow tract-related reintervention (tetralogy of Fallot with atrioventricular septal defect, 95.2% vs
atrioventricular septal defect alone, 86.0% at 5 years;P¼ .332) were comparable between the tetralogy of Fallot
with atrioventricular septal defect and matched control groups.
Conclusions: Late survival and atrioventricular valve function after repair of tetralogy of Fallot with atrioventric-
ular septal defect were excellent. Pulmonary valve preservation and avoidance of an artificial conduit were associ-
ated with greater freedom from right ventricular outflow tract reintervention. In the current era, the surgically
modified history of tetralogy of Fallot with atrioventricular septal defect is not significantly different from that of
isolated tetralogy of Fallot or isolated atrioventricular septal defect. (J Thorac Cardiovasc Surg 2013;145:1477-84)Supplemental material is available online.
Tetralogy of Fallot with atrioventricular septal defect (TOF/
AVSD) has unique anatomic features involving both inlet
and outlet components of the ventricles (ie, the presence of
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The Journal of Thoracic and Carventricular septal defect [VSD], an anteriorly deviated in-
fundibular septum, and subsequent aortic override).1-3
This complex anatomy posed surgical challenges in the
early era of staged repair, resulting in a high operative
mortality of up to 15% to 20%.4-6 The paradigm shift to
primary repair has improved survival in the current
era.1,5,7-9 Nevertheless, the overall reintervention rate
remains high, with estimates of 20% to 50% at 5 years
after repair.7,9,10
Considering the anatomy involving the inlet and outlet
components, the high reintervention rate in this entity is
comprehensible. The reintervention rate for the right
ventricular outflow tract (RVOT) in patients with isolated
TOF has been 10% to 40% at 5 years.11-13 Approximately
10% to 15% of the patients who have undergone repair
for isolated complete AVSD will require reintervention for
their left AVVor left ventricular outflow tract (LVOT) at 5
years after repair.14,15 We sought to determine whether the
inlet and outlet components of patients with TOF/AVSD
might have equivalent functional outcomes and similardiovascular Surgery c Volume 145, Number 6 1477
Abbreviations and Acronyms
AVSD ¼ atrioventricular septal defect
AVV ¼ atrioventricular valve
IQR ¼ interquartile range
LVOT ¼ left ventricular outflow tract
PA ¼ pulmonary artery
PV ¼ pulmonary valve
RVOT ¼ right ventricular outflow tract
TOF/
AVSD
¼ tetralogy of Fallot with atrioventricular
septal defect
VSD ¼ ventricular septal defect
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Dlong-term reintervention rates comparedwith thosewith iso-
lated TOF or isolated AVSD. To investigate this question,
a double case-match studywas performed comparing the an-
atomic characteristics and long-term RVOT and AVV func-
tion between patients with TOF/AVSD and isolated TOF or
isolated AVSD.
METHODS
We retrospectively reviewed the data from all patients who had under-
gone surgical repair of TOF/AVSD from January 1990 to December 2010
at the Hospital for Sick Children (Toronto, Ontario, Canada). The research
ethics board approved the study and waived the requirement for patient con-
sent.Of the 41 patients, 38 had typical TOF/AVSDand 3 hadmore than 50%
aortic override, defined as a double outlet right ventricle/AVSD.Also, 33 pa-
tients (78%) had trisomy 21. A complete preoperative profile is listed in
Table 1. Our surgical strategy shifted from staged repair to primary repair
in the mid-1990s.5 Twenty palliations were performed in 13 patients
(32%) to increase the pulmonary blood flow before definitive repair.
Surgical Technique
All repairs were done with mild (moderate in the early era) hypother-
mic cardiopulmonary bypass with bicaval cannulation. All but 1 patient
underwent closure of septal defects with the standard 2-patch technique.
The ventricular patch used was polyethylene terephthalate fabric (Dacron)
or polytetrafluoroethylene fashioned into a comma shape. The cleft was
completely closed with interrupted polypropylene sutures (Ethicon,
Somerville, NJ) unless a patient had a functional parachute left AVV. Par-
tial annuloplasty was typically performed. Closure of the atrial septal de-
fect was achieved with autologous pericardium. The RVOT muscle
resection was performed using a transatrial and pulmonary approach. Val-
votomy and commissurotomy were routinely performed on the pulmonary
valve (PV). Our institutional criteria to attempt the PV-sparing repair
evolved over time. The policy in the past 15 years has been that PV pres-
ervation was attempted when the PV z-score was 3 to 4 or greater. The
final decision to preserve the PV was determined by the intraoperative
intracardiac pressure and transesophageal echocardiographic findings.
A right ventricular systolic pressure of less than 70% was accepted. If
a significant residual pressure gradient was present at the infundibular
level rather than at the PV, a separate infundibular patch was placed. Pri-
mary transannular patch repair was performed in patients with a severely
hypoplastic PV.
Echocardiographic Evaluation
The original echocardiographic images were evaluated by echocardio-
graphic investigators (N.O., L.M.), whowere unaware of the original echo-
cardiographic report and clinical outcomes. The morphologies of the1478 The Journal of Thoracic and Cardiovascular SurAVVs, ventricles, RVOT, and LVOT were determined. AVV regurgitation
and ventricular function were graded (AVV regurgitation, 0, none/trivial;
1, mild; 2, mildþ/moderate; and 3, moderateþ/severe; and ventricular
function, 0, normal; 1, mildly reduced; 2, moderately reduced; and 3, se-
verely reduced). The ventricular dimensions and AVVannular dimensions
were measured from the apical 4-chamber view and were indexed by the
body surface area. The AVV index was calculated as the left AVV area
divided by the total AVV area.16
Case-Match Control
Patients with isolated TOF or isolated AVSD were selected as case-
match control patients. Three control patients were matched to each study
patient according to the diagnosis. A single best fit was then chosen accord-
ing PV size, indexed PV size, body weight, and body surface area at surgery
for the TOF control patients. For the AVSD control patients, the best fit was
chosen by the preoperative AVV regurgitation grade and AVVindex. Of the
41 patients, 33 (80%) completely met the matching criteria. The remaining
8 patients (20%) were excluded from the case-match analysis, because
they lacked complete echocardiographic review data.
Outcome Assessment
The effects of preoperative anatomic and physiologic status (as deter-
mined by the echocardiographic variables) on clinical and functional out-
comes were analyzed. The clinical outcomes, including freedom from
reintervention, were evaluated. These outcomes were also compared with
respect to the surgical technique used (native PV preserved vs native PV
not preserved). Freedom from reintervention and late functional outcomes,
including RVOT (against isolated TOF group) and AVVand LVOT (against
isolated AVSD group), were compared between patients with TOF/AVSD
and matched control patients.
Statistical Analysis
Continuous data are presented as median (interquartile range [IQR]).
Discrete data are presented as frequencies (percentage). Differences be-
tween the groups were analyzed using the Mann-Whitney U test. Event
frequencies were tested using the chi-square test or Fisher’s exact test.
Freedom from reintervention was analyzed using Kaplan-Meier analysis
and a log-rank test. Competing risk outcomes were analyzed with the cu-
mulative incidence function. Univariable predictors for RVOT reinterven-
tion were explored with Cox regression analysis. The variables that were
significant at the P  .10 level on univariable analysis were included in
a stepwise multivariable Cox regression model. Statistical analysis was
performed using SPSS (version 17.0; IBM Corporation, Armonk, NY) sta-
tistical software.
RESULTS
Preoperative Echocardiographic Findings
The level of RVOT obstruction was subvalvular in 31
(94%), valvular in 32 (97%), supravalvular in 8 (24%),
and at the pulmonary arteries in 1 (3%; Table E1). The
PV z-score and peak pressure gradient across the RVOT
was 2.25 (IQR, 3.37 to 0.13) and 65 mm Hg (IQR,
55-75 mm Hg), respectively. The ventricles and AVVs
were well balanced in most patients (AVV index, 0.47;
IQR, 0.45-0.48; Table E2). Twelve patients (36%) had
moderate or greater AVV regurgitation preoperatively.
RVOT Reconstruction
The RVOTwas reconstructed with the PV preserved in 23
patients (56%; infundibular and main pulmonary arterygery c June 2013
TABLE 1. Perioperative profile
Variable Value
Patient profile
Age (mo) 22.4 (10.8-41.6)
Body weight (kg) 10.4 (7.8-12.7)
BSA (m2) 0.48 (0.43-0.52)
Diagnosis
TOF/AVSD 38 (93)
DORV/AVSD 3 (7)
Trisomy 21 32 (78)
Previous operations n ¼ 13
Blalock-Taussig shunt 10 (24)
PA valvotomy 3 (7)
Surgical 2 (5)
Balloon 1 (2)
Pulmonary arterioplasty 3 (7)
Transannular patch 1 (2)
PA stent 1 (2)
Glenn shunt 1 (2)
Arteriovenous fistula 1 (2)
Operative technique
TOF
PV preserved 23 (56)
Infundibular patch only 3 (7)
PA and infundibular patch 11 (27)
PA patch only 6 (15)
No patch 3 (7)
Transannular patch 11 (27)
PV implant 3 (7)
Right ventricle to PA conduit 4 (10)
AVSD
One-patch repair 1 (2)
Two-patch repair 40 (98)
Reintervention
All reintervention 13 (32)
RVOT-related reintervention 7 (20)
AVV-related reintervention 2 (5)
LVOT-related reintervention 1 (2)
Data presented as median (interquartile range) or n (%). BSA, Body surface area;
TOF, tetralogy of Fallot; AVSD, atrioventricular septal defect; DORV, double outlet
right ventricle; RVOT, right ventricular outflow tract; PA, pulmonary artery;
PV, pulmonary valve; AVV, atrioventricular valve; LVOT, left ventricular outflow
tract.
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D[PA] patch in 11 [27%], infundibular patch only in 3 [7%],
main PA patch only in 6 [15%], and no patch in 3 [7%];
Table 1). Repair with a transannular patch was performed
in 11 patients (27%). The RVOT in the 7 remaining patients
was reconstructed with an artificial valve in 3 (7%) and
a conduit in 4 (10%). The rate of PV preservation during
the past 2 decades was similar (1990-1999, 14/27 [52%];
2000-2011, 9/14 [64%]; P ¼ .447).FIGURE 1. Competing risk plot showing clinical outcomes for the entire
cohort.Survival
There were 3 early deaths and no late deaths. All 3 deaths
occurred before 1998 and were from acute ventricular fail-
ure and low cardiac output. Two deaths were related to early
reoperation for RVOT obstruction and residual muscularThe Journal of Thoracic and CarVSD, respectively. The overall survival was 92.1% at 15
years after repair.
Functional Outcomes and Reintervention
The median follow-up period was 5.9 years (IQR, 0.14-
13.7 years). The competing risk analysis for reintervention
is shown in Figure 1. Freedom from all reintervention at 5,
10, and 15 years was 73.7%, 69.3%, and 52.8%, respec-
tively. Most reoperations occurred within 2 years of repair.
A total of 29 reinterventions (surgery for 22 and catheter for
7) were performed in 13 patients (32%; Table 1). Of these
procedures, 12 (38%) in 7 patients were related to the
RVOT. The reason for reintervention was RVOTobstruction
in 3 patients, pulmonary insufficiency in 2, and both ob-
struction and insufficiency in 2. Reintervention included
PV replacement in 6 patients, RV–PA conduit
replacement in 3, and RVOT balloon dilatation or stenting
in 3. Freedom from RVOT-related reintervention was sig-
nificantly greater for patients with a preserved PV (95.2%
vs 35.0% at 15 years; P¼ .046; Figure 2). Two reoperations
were required for left AVV regurgitation at 1 year and 13.8
years after surgery. No right AVV reintervention was
required. One patient had mild residual left AVV
regurgitation and one had moderate left AVV regurgitation.
There were no patients in this series who required valve re-
placement. One patient required LVOT fibromuscular ring
resection 1 year after the initial repair. RVOT reconstruction
with a nonpreserved PV (P ¼ .040) and a lower PV z-score
(P ¼ .048) were identified as risk factors for RVOT-related
reintervention.
The latest echocardiogram showed a median RVOT pres-
sure gradient of 25 mm Hg (IQR, 12-32 mm Hg; Table 2).
Moderate or more pulmonary insufficiency was seen in 13
patients (56%). Two patients (5%) had moderate or more
AVV regurgitation. Residual LVOT obstruction was noted
in 1 patient (2%) who underwent LVOT fibromuscular
ring resection.diovascular Surgery c Volume 145, Number 6 1479
FIGURE 2. Freedom from right ventricular outflow tract (RVOT) reinter-
vention stratified by RVOT reconstruction type. Freedom from RVOT rein-
tervention in pulmonary valve (PV)-preserved patients is significantly
greater than that of patients with their PVs not preserved.
TABLE 2. Postoperative case-match control (tetralogy of Fallot)
Variable
TOF/AVSD
(n ¼ 33)
TOF
(n ¼ 33)
P
value
Operative technique
PV preserved, no
infundibular patch
8 (24) 21 (64) .001
PV preserved,
infundibular patch
11 (33) 3 (9) .033
PV not preserved 14 (42) 9 (27) .196
Discharge echocardiogram
Age at echocardiogram
(mo)
19.1 (10.0-38.6) 8.1 (6.3-25.8) .012
Interval from surgery
(mo)
0.23 (0.03-0.44) 0.16 (0.10-0.26) .434
RVOT gradient 20 (13-27) 16 (9-28) .796
Pulmonary insufficiency
None 12 (36) 5 (15) .049
Trivial 1 (3) 6 (18) .105
Mild 4 (12) 4 (12) 1.000
Mildþ 3 (9) 4 (12) 1.000
Moderate 4 (12) 2 (6) .672
Severe 4 (12) 12 (36) .042
Indeterminate 5 (15) 0 (0) .053
Long-term follow-up
echocardiogram
n ¼ 23 n ¼ 17
Age at echocardiogram
(mo)
140.0 (60.5-195.7) 33.5 (18.7-64.1) .001
Interval from surgery
(mo)
113.6 (24.3.1-157.8) 1.7 (1.1-53.4) .001
RVOT gradient 25 (12-32) 15 (9-30) .011
Pulmonary insufficiency
None 1 (4) 0 (0) 1.000
Trivial 2 (9) 3 (18) .634
Mild 5 (22) 5 (29) .717
Mildþ 2 (9) 3 (18) .634
Moderate 3 (13) 2 (12) 1.000
Severe 10 (43) 4 (23) .315
Data presented asmedian (interquartile range) or n (%).TOF,Tetralogy of Fallot;AVSD,
atrioventricular septal defect;PV, pulmonary valve;RVOT, right ventricular outflow tract.
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DCase-Match Control: TOF/AVSD Versus Isolated
TOF
No difference was found in body size between the 2
groups. Patient age at surgery was older in the TOF/
AVSD group (19.0 vs 7.95months;P¼ .012). No difference
was found in the level of RVOT obstruction between the
groups. Most patients in both groups had both subvalvular
and valvular stenosis (Table E1). The preoperative RVOT
peak pressure gradient was greater in the isolated TOF
group (74 vs 65 mm Hg; P ¼ .023). The TOF/AVSD group
required repair with an infundibular patch more often than
did the isolated TOF group (11 vs 3 patients; P ¼ .033;
Table 2). The PV preservation rate was comparable between
the groups (TOF/AVSD, 19 [58%] vs isolated TOF, 24
[73%]; P ¼ .196). Among the patients with a preserved
PV, no differences were seen in the preoperative PV z-score
between the groups (1.94 vs 1.62; P ¼ .420); however,
the PV z-score in the TOF/AVSD group was significantly
greater than that in the isolated TOF group among the pa-
tients with a transannular patch (P ¼ .014; Figure 3). The
distribution of the PV z-score in the TOF/AVSD group
was equal, regardless of the type of RVOT reconstruction
(PV preserved, 1.94 vs PV not preserved, 2.32;
P ¼ .702). In contrast, in the isolated TOF group, the PV
z-score in patients with a preserved PV was significantly
greater than that of patients with a transannular patch
(1.62 vs 4.33; P ¼ .001). The follow-up RVOT peak
pressure gradient was greater in the TOF/AVSD group
than in the isolated TOF group (P ¼ .011). No difference
was found in the severity of pulmonary insufficiency
between the 2 groups (Table 2). Freedom from RVOT-
related reinterventionwas comparable between the 2 groups1480 The Journal of Thoracic and Cardiovascular Sur(TOF/AVSD, 88.6% vs isolated TOF, 83.9% at 5 years;
P ¼ .809; Figure 4, A).Case-MatchControl:TOF/AVSDVersus IsolatedAVSD
Patient age at surgery was older in the TOF/AVSD group
than in the isolated AVSD group (19.0 vs 5.5 months;
P<.001). The AVV index was comparable between the 2
groups. No difference was seen in the overall severity of
preoperative AVV regurgitation between the groups, al-
though a nonsignificant trend toward more moderate AVV
regurgitation was present in the TOF/AVSD group (Table
E2). The indexed left and right AVV diameters and left
and right ventricular size were larger in the patients with
isolated AVSD (P<.001). No preoperative LVOT stenosis
was present in either group. The isolated AVSD group
tended to have more right AVV regurgitation at dischargegery c June 2013
FIGURE 3. Relationship between preoperative pulmonary valve (PV) size
and right ventricular outflow tract (RVOT) reconstruction for patients with
TOF/AVSD compared with isolated tetralogy of Fallot. Numbers shown
below boxes represent proportion of each category. The top and bottom of
the boxes represent the 25th and 75th percentile (interquartile range),
respectively. The horizontal line represents the median. The top vertical
lines represent the maximum value and the bottom vertical lines represent
the minimum values. Gray indicates patients with tetralogy of Fallot/atrio-
ventricular septal defect; white, patients with isolated tetralogy of Fallot.
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D(P ¼ .053), but no difference was seen in the AVV regurgi-
tation grades between the groups at the latest follow-up ex-
amination (Table 3). Freedom from AVV/LVOT-related
reintervention was comparable between the 2 groups
(TOF/AVSD, 95.2% vs isolated AVSD, 86.0% at 5 years;
P ¼ .332; Figure 4, B).FIGURE 4. Freedom from reintervention between our cohort and case-
matched controls. A, Right ventricular outflow tract (RVOT)-related rein-
tervention. B, atrioventricular valve (AVV)/left ventricular outflow tract
(LVOT) reintervention. C, All reinterventions.DISCUSSION
Repair of TOF/AVSD involves reconstruction of both in-
let and outlet portions of the ventricles, which resulted in
high operative mortality in the early era. A better under-
standing of the anatomy and physiology and the introduc-
tion of primary repair in infancy have significantly
improved survival.3,5,8-10 Our interest has shifted toward
investigating the long-term functional outcomes, because
this entity potentially has the dual late hazard of an RVOT
or AVVs that can become stenosed, obstructed, or dysfunc-
tional. This study attempted to analyze the long-term func-
tional outcomes of the inlet and outlet components
separately by applying a double case-match control meth-
odology. The late survival in this cohort was excellent
(92% at 15 years). Survival was consistent with that from
other recent series.5,8-10,17 Approximately one third of the
cohort required some form of reintervention by 10 years
postoperatively. Reintervention was mainly performed on
the RVOT. AVV and LVOT reinterventions were rare.
Despite having similar preoperative PV z-scores and
lower RVOT pressure gradients, the TOF/AVSD group
required repair with a transannular patch more often thanThe Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 6 1481
TABLE 3. Postoperative case-match control (atrioventricular septal
defect)
Variable
TOF/AVSD
(n ¼ 33)
AVSD
(n ¼ 33)
P
value
Discharge echocardiogram
Age at echocardiogram
(mo)
19.1 (10.0-38.6) 5.9 (5.3-6.9) <.001
Interval from surgery
(mo)
0.23 (0.03-0.44) 0.25 (0.16-0.38) .572
LVOT obstruction
Yes 2 (6) 1 (3) 1.000
No 29 (88) 31 (94) .672
Indeterminate 2 (6) 1 (3) 1.000
Right AVV regurgitation
None 7 (21) 3 (9) .170
Trivial 5 (15) 5 (15) 1.000
Mild 16 (48) 16 (48) 1.000
Mildþ 3 (9) 3 (9) 1.000
Moderate 0 (0) 5 (15) .053
Indeterminate 2 (6) 1 (3) 1.000
Left AVV regurgitation
None 10 (30) 1 (3) .006
Trivial 1 (3) 4 (12) .355
Mild 18 (55) 19 (58) .804
Mildþ 2 (6) 5 (15) .427
Moderate 0 (0) 3 (9) .238
Indeterminate 2 (6) 1 (3) 1.000
Long-term follow-up
echocardiogram
n ¼ 23 n ¼ 22
Age at echocardiogram
(mo)
140.0 (60.5-195.7) 65.2 (47.7-74.9) .004
Interval from surgery
(mo)
113.6 (24.3-157.8) 57.1 (43.3-69.5) .048
LVOT obstruction
Yes 1 (4) 0 (0) 1.000
No 22 (96) 22 (100) 1.000
Right AVV regurgitation
None 8 (35) 2 (9) .071
Trivial 0 (0) 4 (18) .049
Mild 13 (57) 12 (55) .894
Mildþ 1 (4) 2 (9) .608
Moderate 1 (4) 2 (9) .608
Left AVV regurgitation
None 3 (13) 1 (5) .608
Trivial 2 (9) 4 (18) .414
Mild 13 (57) 12 (55) .894
Mildþ 2 (9) 1 (5) 1.000
Moderate 2 (9) 2 (9) 1.000
Moderateþ 0 (0) 1 (5) .489
Severe 0 (0) 1 (5) .489
Indeterminate 1 (4) 0 (0) 1.000
Data presented as median (interquartile range) or n (%). TOF, Tetralogy of Fallot;
AVSD, atrioventricular septal defect; LVOT, left ventricular outflow tract; AVV, atrio-
ventricular valve.
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Dthe isolated TOF group. The preoperative AVV/LVOT
anatomy and physiology and long-term AVV/LVOT func-
tion after repair were comparable to those of the isolated1482 The Journal of Thoracic and Cardiovascular SurAVSD group. Freedom from all reintervention in the
TOF/AVSD group was slightly lower than that in the
isolated AVSD group and almost identical to that of the
isolated TOF group (P ¼ .087; Figure 4, C).
RVOT Reconstruction: Effect of Preoperative
Anatomy and Physiology
The anatomy and dimensions of the RVOT and the mode
of RVOT obstruction in the TOF/AVSD group were very
similar to those in the isolated TOF group. The preoperative
RVOT peak pressure gradient across the RVOTwas lower in
the TOF/AVSD group than in the isolated TOF group, for
which we found no clear explanation. Despite having
a PV size similar to that of the isolated TOF group, this
study showed a significantly lower rate of PVannulus pres-
ervation with a high incidence of infundibular patch use in
the TOF/AVSD group. In the past, transannular patch repair
was performed even in patients with a reasonable PV
annulus z-score in the TOF/AVSD group. A greater correla-
tion was found between the preoperative PV size and the
need for transannular incision in the isolated TOF group,
indicating that the preoperative PV size predicts RVOT
reconstruction.
First, this was partly because of our evolving institutional
strategy in the past 2 decades, in which we attempted more
PV-preserving surgery combined with placement of an in-
fundibular patch.18 Only 9 of the 33 patients (27%) in the
cohort who were available for the echocardiographic analy-
sis had a PV z-score of less than 4. One could speculate
that we might be able to achieve a PVannulus preservation
rate close to 70% with our current strategy. In addition,
a transannular or infundibular incision was often used to
expose the anteriorly deviated VSD, which might have
increased the likelihood of a non–PV-preserved re-
pair.2,3,8-10 Overall, approximately 30% of the cohort had
unfavorable RVOT anatomy for PV preservation surgery.
The PV preservation rate in this cohort was 56%,
significantly greater than that in other series, which had
PV preservation rates ranging from 13% to 21%.9,10
From the anatomic observation and our current strategy of
using the infundibular patch technique, we believe that
a PV preservation rate of 70% could be achievable in this
entity.
RVOT Reintervention
Our study showed superior outcomes in RVOT-related re-
intervention in PV-preserved patients, with freedom from
reintervention of 95.2% at 15 years compared with 35%
in non–PV-preserved patients. Shuhaiber and colleagues9
reported that the use of conduits required a greater RVOT
reintervention rate than other types of reconstruction, such
as transannular and infundibular patches. Brancaccio and
colleagues10 showed consistent findings, with freedom
from reintervention of 62.2% at 10 years in the nonconduitgery c June 2013
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Dgroup compared with 14.0% in the conduit group. Among 7
patients who received an artificial valve or conduit at the
initial repair in the present series, our retrospective review
revealed 6 patients who could have undergone transannular
patch repair (1 patient had an abnormal coronary artery
crossing the RVOT, which necessitated conduit placement).
These findings underscore the importance of PV preserva-
tion and avoidance of an artificial valve or conduit to min-
imize or delay RVOT reintervention. However, it is
important to mention that the RVOT reintervention profile
in the patients with TOF/AVSD in this series was equivalent
to what was achieved in patients with isolated TOF.
AVV in Patients With TOF/AVSD
The striking difference between the hearts with TOF/
AVSD and isolated AVSD was the ventricular and AVV
dimensions. Because of the presence of RVOT obstruction
and subsequent lower pulmonary/systemic flow ratio, the
size of both the ventricles and the AVVs in those with
TOF/AVSD was considerably smaller than the size in
the isolated ‘‘volume-loaded’’ AVSD hearts. No difference
was seen in overall degree of preoperative AVV regurgita-
tion, although 8 patients with TOF/AVSD had moderate
AVV regurgitation preoperatively. This could be explained
in part by the late timing of repair in the early era. AVV
regurgitation could have developed over time while the
patient was awaiting definitive repair (5 of 8 patients un-
derwent repair at 1 year old). The adverse effect of
a systemic-to-pulmonary shunt and subsequent volume
overload on AVV function has been well described,7 al-
though only 1 of 8 patients had undergone a previous
shunt procedure. It is also possible that the presence of
RVOT obstruction (ie, increase in afterload) might have
some adverse effect on AVV competency. However, the
early and late AVV function in patients with TOF/AVSD
was excellent. The mechanism and timing of left AVV re-
intervention was nonspecific. Significant pulmonary insuf-
ficiency or residual RVOT obstruction had no specific
adverse effects on the right AVV during the median
follow-up of 5.9 years; however, the long-term effect of
chronic pulmonary insufficiency on right AVV function
has not been determined.
LVOT in Patients With TOF/AVSD
The LVOT dimensions in those with TOF/AVSD were
significantly smaller than those in patients with isolated
AVSD. An overriding aorta in the presence of an AVSD-
type VSD might pose the threat of potential acute and
chronic LVOTobstruction. All patients in the present series
received a comma-shape VSD patch to avoid LVOT ob-
struction. No acute LVOT obstruction developed, and the
1 incidence of LVOT reintervention was not related to the
patch configuration but, rather, to an isolated fibromuscular
ring. No significant LVOT pressure gradient was noted inThe Journal of Thoracic and Carthe latest follow-up examination. Overall, the LVOT in
those with TOF/AVSD has had favorable long-term
outcomes.Study Limitations
The main limitation of this study was its retrospective na-
ture. The surgical techniques and postoperative manage-
ment have evolved significantly in the past 2 decades,
which influenced the clinical outcomes in our cohort.
Also, the present study did not focus on the preoperative
RVOT dimensions, which could have had an effect on the
type of repair and subsequent RVOT functional outcomes.CONCLUSIONS
The results of our study have shown that late survival and
functional outcomes after repair of TOF/AVSD are excel-
lent. PV preservation and the avoidance of an artificial
conduit were related to greater freedom from RVOT reinter-
vention. The preoperative RVOT and AVV anatomy and
physiology in those with TOF/AVSD are similar to those
in patients with isolated TOF and isolated AVSD, respec-
tively. The long-term AVVand LVOT function in the pres-
ent cohort were excellent. In the current era, the surgically
modified history of TOF/AVSD was not significantly differ-
ent from that of either isolated TOF or isolated AVSD.
The authors thank Dr Anusha Jegatheeswaran for her kind
assistance.References
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TABLE E1. Preoperative case-match control (tetralogy of Fallot)
Variable TOF/AVSD (n ¼ 33) TOF (n ¼ 33) P value
Weight (kg) 7.9 (5.2-10.6) 8.5 (6.2-10.19) .428
BSA (m2) 0.44 (0.31-0.52) 0.39 (0.31-0.49) .547
Interval from echocardiography to surgery (mo) 2.3 (1.1-4.4) 0.72 (0.23-1.48) <.001
Age at surgery (mo) 19.0 (10.3-36.2) 7.95 (6.14-25.69) .012
Weight at surgery (kg) 10.0 (6.5-12.5) 9.0 (6.8-10.6) .401
BSA at surgery (m2) 0.47 (0.39-0.52) 0.46 (0.40-0.49) .621
VSD morphology
VSD size
Small 1 (3) 1 (3) 1.000
Medium 2 (6) 4 (12) .672
Large 30 (91) 28 (85) .708
Nonrestrictive VSD 33 (100) 30 (91) .238
VSD direction of flow in systole (left to right) 33 (100) 33 (100) —
Additional VSD
Yes 1 (3) 0 (0) 1.000
No 25 (76) 33 (100) .005
Indeterminate 7 (21) 0 (0) .011
RVOT
PV annulus (cm) 0.89 (0.74-1.00) 0.87 (0.76-0.97) .883
Indexed PV annulus (cm/m2) 2.16 (1.68-2.72) 2.16 (1.73-2.90) .837
PV z-score 2.25 (3.37 to 0.13) 2.13 (3.43 to 0.54) .822
PV regurgitation
None 23 (70) 26 (79) .574
Trivial 1 (3) 5 (15) .197
Mild 6 (18) 2 (6) .258
Indeterminate 3 (9) 0 (0) .238
Outflow tract obstruction 33 (100) 33 (100) —
Obstruction level
Subvalve 31 (94) 31 (94) 1.000
Valve 32 (97) 32 (97) 1.000
Supravalve 8 (24) 13 (39) .290
PAs 1 (3) 1 (3) .613
Peak gradient (mm Hg) 65 (55-75) 74 (65-85) .023
Right PA size (cm) 0.64 (0.56-0.76) 0.65 (0.55-0.76) .883
Right PA indexed (cm/m2) 1.59 (1.29-1.80) 1.55 (1.38-1.93) .509
Left PA size (cm) 0.60 (0.48-0.75) 0.66 (0.51-0.69) .934
Left PA indexed (cm/m2) 1.39 (1.25-1.71) 1.44 (1.27-1.74) .542
Data presented as median (interquartile range) or n (%). TOF, Tetralogy of Fallot; AVSD, atrioventricular septal defect; BSA, body surface area; VSD, ventricular septal defect;
RVOT, right ventricular outflow tract; PV, pulmonary valve; PA, pulmonary artery.
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TABLE E2. Preoperative case-match control (atrioventricular septal defect)
Variable TOF/AVSD (n ¼ 33) AVSD (n ¼ 33) P value
Weight (kg) 7.9 (5.2-10.6) 4.5 (3.3-5.5) <.001
BSA (m2) 0.44 (0.31-0.52) 0.25 (0.21-0.28) <.001
Interval from echocardiography to surgery (mo) 2.3 (1.1-4.4) 1.0 (0.3-4.5) .124
Age at surgery (mo) 19.0 (10.3-36.2) 5.5 (4.9-6.7) <.001
Weight at surgery (kg) 10.0 (6.5-12.5) 5.6 (5.1-6.1) <.001
BSA at surgery (m2) 0.47 (0.39-0.52) 0.32 (0.30-0.35) <.001
Right versus left morphology
Ventricular dominance
RV 4 (12) 3 (9) 1.000
LV 0 (0) 2 (6) .492
None 29 (88) 28 (85) 1.000
Angle RV inflow-to-LV inflow () 96 (85-107) 137 (110-146) <.001
AVV size (cm) 3.51 (2.92-3.83) 2.30 (1.90-2.60) <.001
Indexed right AVV area (cm2/m2) 7.66 (6.57-8.92) 7.84 (6.69-9.65) .479
Indexed left AVV area (cm2/m2) 6.85 (5.57-7.56) 7.20 (5.95-9.12) .203
Indexed total AVV area (cm2/m2) 14.42 (12.55-16.30) 15.00 (12.38-18.42) .352
AVV index 0.47 (0.45-0.48) 0.48 (0.46-0.50) .098
ASD morphology
Ostium primum ASD
Yes 32 (97) 32 (97) 1.000
No 0 (0) 0 (0) —
Indeterminate 1 (3) 1 (3) 1.000
Restrictive primum ASD
Yes 2 (6) 1 (3) 1.000
No 29 (88) 31 (94) .672
Indeterminate 2 (6) 1 (3) 1.000
Additional ASD
Yes 9 (27) 26 (79) <.001
No 9 (27) 4 (12) .215
Indeterminate 15 (45) 3 (9) .002
VSD morphology
Inlet VSD size
Small 1 (3) 2 (6) 1.000
Medium 2 (6) 2 (6) 1.000
Large 30 (91) 29 (88) 1.000
Restrictive inlet VSD
Yes 0 (0) 2 (6) .492
No 33 (100) 29 (88) .114
Indeterminate 0 (0) 2 (6) .492
Inlet VSD direction of flow in systole
Left to right 33 (100) 29 (88) .114
Indeterminate 0 (0) 4 (12) .114
Additional VSD
Yes 1 (3) 3 (9) .613
No 25 (76) 20 (61) .186
Indeterminate 7 (21) 10 (30) .398
AVSD morphology
Rastelli type
A 4 (12) 25 (76) <.001
C 29 (88) 4 (12) <.001
Indeterminate 0 (0) 0 (0) .114
(Continued)
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TABLE E2. Continued
Variable TOF/AVSD (n ¼ 33) AVSD (n ¼ 33) P value
AVV regurgitation
Right AVV regurgitation
None 10 (29) 6 (18) .251
Trivial 10 (29) 9 (27) .786
Mild 9 (26) 12 (36) .428
Moderate 3 (9) 4 (12) 1.000
Severe 1 (3) 1 (3) 1.000
Indeterminate 1 (3) 1 (3) 1.000
Left AVV regurgitation
None 8 (24) 18 (55) .012
Trivial 9 (26) 4 (12) .215
Mild 9 (26) 7 (21) .769
Moderate 8 (24) 3 (9) .185
Severe 0 (0) 0 (0) —
Indeterminate 0 (0) 1 (3) 1.000
Central AVV regurgitation
None 29 (85) 26 (79) .322
Trivial 0 (0) 0 (0) —
Mild 3 (9) 1 (3) .613
Moderate 0 (0) 4 (12) .114
Severe 0 (0) 1 (3) 1.000
Indeterminate 2 (6) 1 (3) 1.000
Right AVV
Diameter (cm) 2.30 (2.02-2.64) 1.79 (1.57-1.93) <.001
Indexed diameter (cm/m2) 5.56 (4.90-6.47) 7.09 (6.67-7.36) <.001
Color inflow diameter at annulus (cm) 1.83 (1.53-1.99) 1.46 (1.29-1.67) .001
Indexed color inflow diameter at annulus (cm/m2) 4.13 (3.67-4.88) 5.76 (5.18-6.16) <.001
Left AVV
Diameter (cm) 1.92 (1.61-2.23) 1.44 (1.28-1.62) <.001
Indexed diameter (cm/m2) 4.55 (3.98-5.44) 5.71 (5.32-6.15) <.001
Color inflow diameter at annulus (cm) 1.52 (1.38-1.78) 1.22 (1.02-1.28) <.001
Indexed color inflow diameter at annulus (cm/m2) 3.77 (3.05-4.56) 4.72 (4.18-5.08) <.001
Papillary muscle abnormalities
The categories are:
Yes 2 (6) 1 (3) 1.000
No 28 (85) 31 (94) .427
Indeterminate 3 (9) 1 (3) .613
Right ventricle
Ventricular dysfunction 1.000
Yes 0 (0) 1 (3)
No 33 (100) 32 (97)
Apex forming 33 (100) 33 (100) —
Length (cm) 3.57 (3.39-3.94) 2.90 (2.46-3.19) <.001
Indexed length (cm/m2) 8.42 (7.51-10.07) 11.19 (10.58-11.92) <.001
Width (cm) 1.96 (1.76-2.32) 1.80 (1.55-2.15) .059
Indexed width (cm/m2) 4.88 (4.12-6.12) 6.96 (6.28-7.96) <.001
Left ventricle
Ventricular dysfunction 0 (0) 0 (0) —
Apex forming 33 (100) 33 (100) —
Length (cm) 3.41 (3.15-3.89) 3.09 (2.77-3.49) .005
Indexed length (cm/m2) 8.07 (7.52-9.77) 12.15 (11.40-13.24) <.001
Width (cm) 1.79 (1.55-2.15) 1.65 (1.46-1.93) .116
Indexed width (cm/m2) 4.59 (3.83-5.72) 6.62 (6.12-7.37) <.001
(Continued)
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TABLE E2. Continued
Variable TOF/AVSD (n ¼ 33) AVSD (n ¼ 33) P value
LVOT
Aortic annulus (cm) 1.39 (1.13-1.64) 0.80 (0.70-0.88) <.001
Indexed aortic annulus (cm/m2) 3.36 (2.71-3.94) 3.16 (2.87-3.33) .251
LVOT diameter (cm) 1.04 (0.95-1.32) 0.81 (0.75-0.90) <.001
Indexed LVOT diameter (cm/m2) 2.78 (2.30-3.28) 3.24 (2.88-3.54) .006
Aortic valve regurgitation
None 28 (85) 31 (94) .427
Trivial 4 (12) 0 (0) .114
Mild 1 (3) 2 (6) 1.000
Outflow tract obstruction 0 (0) 0 (0) —
Stenosis 0 (0) 0 (0) —
Associated cardiac lesions
Septal malalignment 1 (3) 1 (3) 1.000
Override 4 (12) 3 (9) 1.000
Data presented as median (interquartile range) or n (%). TOF, Tetralogy of Fallot; AVSD, atrioventricular septal defect; BSA, body surface area; RV, right ventricular; LV, left
ventricular; AVV, atrioventricular valve; ASD, atrial septal defect; VSD, ventricular septal defect; LVOT, left ventricular outflow tract.
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